Firesorb bioresorbable scaffold for de novo coronary artery disease: 1-year clinical outcomes

Firesorb bioresorbable scaffold for de novo coronary artery disease: 1-year clinical outcomes

Abstract Background The first-generation bioresorbable scaffolds (BRS) have been associated with higher rates of device-related adverse outcomes in comparison to everolimus-eluting stents. We aimed to evaluate the efficacy and safety of the thinner-strut (100/125 μm) poly-L-lactic acid-based sirolim...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Jiang, Changling Li, Delong Chen, Lei Song, Zhanqian Cui, Ping Li, Lijun Gan, Yundai Chen, Hui Li, Shaobin Jia, Shenghu He, Wen Lu, Runlin Gao, Jianan Wang, on behalf of the FUTURE III Investigators
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Medicine
Subjects:
Bioresorbable scaffolds
Coronary artery diseases
Percutaneous coronary intervention
Target lesion failure
Online Access:https://doi.org/10.1186/s12916-025-04254-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12916-025-04254-0

Similar Items